E. Castellano
Molecular Biology · 2011
A researcher in the Science corpus: 1 paper; trusts 3 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 45 citations into it
Whom E. Castellano trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from E. Castellano's perspective
Ordered by how strongly the researchers E. Castellano trusts endorse each paper. Same corpus, a different order for every researcher.
- High Frequency of Mutations of the PIK3CA Gene in Human Cancers (Science)
- Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR (Proceedings of the National Academy of Sciences of the United States of America)
- The phosphoinositide 3-kinase pathway. (Science)
- The TSC1-2 tumor suppressor controls insulin–PI3K signaling via regulation of IRS proteins (Journal of Cell Biology)
- TSC2 mediates cellular energy response to control cell growth and survival. (Cell)
- TOR signaling in growth and metabolism. (Cell)
- PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients. (Cancer Cell)
- The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism (Nature reviews genetics)
- mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. (Cell)
- The phosphatidylinositol 3-Kinase–AKT pathway in human cancer (Nature Reviews. Cancer)
Their papers
- RAS Interaction with PI3K: More Than Just Another Effector Pathway. (2011) — 736 citations